Rockefeller Capital Management
TSVT

Rockefeller Capital Management’s 2seventy bio TSVT Stock Holding History

Rockefeller Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2
Closed – – 3751
2022
Q4 		$0 Hold
2
– – ﹤0.01% 4216
2022
Q3 		$0 Sell
2
-27
-93% -$401 ﹤0.01% 4376
2022
Q2 		$0 Buy
+29
New +$395 ﹤0.01% 4395

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rockefeller Capital Management's TSVT Position: Q1 2023 in Review

Rockefeller Capital Management sold out of 2seventy bio (TSVT) in Q1 2023, closing a stake of 2 shares.

Rockefeller Capital Management first reported a position in TSVT in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q4 2022. 146 funds tracked by Wall St. Rank hold TSVT as of Q1 2023.

  • Rockefeller Capital Management reported no remaining 2seventy bio position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 2 2seventy bio shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in 2seventy bio in Q2 2022 and held it in 3 quarters.
  • Rockefeller Capital Management's 2seventy bio position peaked at $0 in Q4 2022.
  • 146 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.